Skip to main content
. 2022 Jul 1;13:939344. doi: 10.3389/fimmu.2022.939344

Table 2.

Association of clinicopathological characteristics with overall survival using univariate or multivariate Cox regression analysis.

Characteristics Total (N) Univariate analysis Multivariate analysis
Hazard ratio (95% CI) p-value Hazard ratio (95% CI) p-value
Age (≤60 vs. >60) 501 1.252 (0.956–1.639) 0.102
Gender (Female vs. Male) 501 0.764 (0.574–1.018) 0.066 0.975 (0.611–1.556) 0.915
Clinical stage (Stage I and Stage II vs. Stage III and Stage IV) 487 1.217 (0.878–1.688) 0.238
T stage (T1 and T2 vs. T3 and T4) 486 1.245 (0.932–1.661) 0.137
N stage (N0 vs. N1 and N2 and N3) 479 1.263 (0.964–1.653) 0.090 1.603 (0.994–2.585) 0.053
M stage (M0 vs. M1) 476 4.745 (1.748–12.883) 0.002 2.041 (0.241–17.265) 0.513
Primary therapy outcome (PD and SD and PR vs. CR) 417 0.182 (0.124–0.268) <0.001 0.209 (0.125–0.350) <0.001
Histologic grade (G1 vs. G2 and G3) 480 1.592 (1.025–2.474) 0.039 1.275 (0.590–2.756) 0.537
Lymphovascular invasion (No vs. Yes) 340 1.699 (1.211–2.384) 0.002 1.657 (1.025–2.680) 0.039
Lymph node neck dissection (No vs. Yes) 498 0.731 (0.526–1.016) 0.062 0.667 (0.289–1.543) 0.344
DCBLD1(High vs. Low) 501 0.707 (0.540–0.925) 0.012 0.631 (0.410–0.971) 0.036
Radiation therapy (No vs. Yes) 440 0.613 (0.452–0.831) 0.002 0.534 (0.327–0.871) 0.012
Race (White vs. Black or African American and Asian) 485 1.470 (0.973–2.220) 0.067 1.256 (0.654–2.409) 0.494

Bold values P<0.05